ID   PAK6_HUMAN              Reviewed;         681 AA.
AC   Q9NQU5; A8K2G2; B3KYB0; G5E9R2;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   12-OCT-2022, entry version 198.
DE   RecName: Full=Serine/threonine-protein kinase PAK 6;
DE            EC=2.7.11.1;
DE   AltName: Full=PAK-5;
DE   AltName: Full=p21-activated kinase 6;
DE            Short=PAK-6;
GN   Name=PAK6; Synonyms=PAK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH AR.
RX   PubMed=11278661; DOI=10.1074/jbc.m010311200;
RA   Yang F., Li X., Sharma M., Zarnegar M., Lim B., Sun Z.;
RT   "Androgen receptor specifically interacts with a novel p21-activated
RT   kinase, PAK6.";
RL   J. Biol. Chem. 276:15345-15353(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wagner T., Puls A., Frischauf A.M., Hall A.;
RT   "Pak5, a new member of the p21-activated kinase family, affects Cdc42
RT   signalling to the actin cytoskeleton.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INTERACTION WITH AR AND ESR1.
RX   PubMed=11773441; DOI=10.1210/mend.16.1.0753;
RA   Lee S.R., Ramos S.M., Ko A., Masiello D., Swanson K.D., Lu M.L., Balk S.P.;
RT   "AR and ER interaction with a p21-activated kinase (PAK6).";
RL   Mol. Endocrinol. 16:85-99(2002).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATION OF AR.
RX   PubMed=14573606; DOI=10.1074/jbc.m311145200;
RA   Schrantz N., da Silva Correia J., Fowler B., Ge Q., Sun Z., Bokoch G.M.;
RT   "Mechanism of p21-activated kinase 6-mediated inhibition of androgen
RT   receptor signaling.";
RL   J. Biol. Chem. 279:1922-1931(2004).
RN   [9]
RP   PHOSPHORYLATION BY MAP2K6, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF SER-165;
RP   SER-560 AND TYR-566.
RX   PubMed=15550393; DOI=10.1074/jbc.m406701200;
RA   Kaur R., Liu X., Gjoerup O., Zhang A., Yuan X., Balk S.P., Schneider M.C.,
RA   Lu M.L.;
RT   "Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP
RT   kinase.";
RL   J. Biol. Chem. 280:3323-3330(2005).
RN   [10]
RP   INTERACTION WITH IQGAP1 AND PPM1B.
RX   PubMed=18642328; DOI=10.1002/pros.20787;
RA   Kaur R., Yuan X., Lu M.L., Balk S.P.;
RT   "Increased PAK6 expression in prostate cancer and identification of PAK6
RT   associated proteins.";
RL   Prostate 68:1510-1516(2008).
RN   [11]
RP   FUNCTION.
RX   PubMed=20054820; DOI=10.1002/pros.21114;
RA   Zhang M., Siedow M., Saia G., Chakravarti A.;
RT   "Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of
RT   prostate cancer cells.";
RL   Prostate 70:807-816(2010).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 383-681, AND PHOSPHORYLATION AT
RP   SER-560.
RA   Filippakopoulos P., Berridge G., Bray J., Burgess N., Colebrook S., Das S.,
RA   Eswaran J., Gileadi O., Papagrigoriou E., Savitsky P., Smee C.,
RA   Turnbull A., Sundstrom M., Arrowsmith C., Weigelt J., Edwards A.,
RA   Von Delft F., Knapp S.;
RT   "Crystal structure of the human p21-activated kinase 6.";
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 11-45 IN COMPLEX WITH CDC42.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of human CDC42 in complex with the CRIB domain of
RT   human p21-activated kinase 6 (PAK6).";
RL   Submitted (JAN-2007) to the PDB data bank.
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-3.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-76; LYS-184; GLU-205; THR-208; MET-210;
RP   ARG-215; LEU-337; VAL-376 AND ARG-514.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase that plays a role in the
CC       regulation of gene transcription. The kinase activity is induced by
CC       various effectors including AR or MAP2K6/MAPKK6. Phosphorylates the
CC       DNA-binding domain of androgen receptor/AR and thereby inhibits AR-
CC       mediated transcription. Inhibits also ESR1-mediated transcription. May
CC       play a role in cytoskeleton regulation by interacting with IQGAP1. May
CC       protect cells from apoptosis through phosphorylation of BAD.
CC       {ECO:0000269|PubMed:14573606, ECO:0000269|PubMed:20054820}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound CDC42/p21
CC       and RAC1 (By similarity). Interacts with the androgen receptor AR and
CC       the estrogen receptor ESR1. Interacts with IQGAP1 and PPM1B.
CC       {ECO:0000250, ECO:0000269|PubMed:11278661, ECO:0000269|PubMed:11773441,
CC       ECO:0000269|PubMed:18642328, ECO:0000269|Ref.13}.
CC   -!- INTERACTION:
CC       Q9NQU5; P60953: CDC42; NbExp=4; IntAct=EBI-1053685, EBI-81752;
CC       Q9NQU5; O75031: HSF2BP; NbExp=3; IntAct=EBI-1053685, EBI-7116203;
CC       Q9NQU5; Q5S007: LRRK2; NbExp=2; IntAct=EBI-1053685, EBI-5323863;
CC       Q9NQU5; Q9H4E5: RHOJ; NbExp=4; IntAct=EBI-1053685, EBI-6285694;
CC       Q9NQU5; Q96L33: RHOV; NbExp=3; IntAct=EBI-1053685, EBI-8538631;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Cotranslocates into
CC       nucleus with AR in response to androgen induction.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NQU5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQU5-2; Sequence=VSP_056733;
CC   -!- TISSUE SPECIFICITY: Selectively expressed in brain and testis, with
CC       lower levels in multiple tissues including prostate and breast.
CC       {ECO:0000269|PubMed:11278661, ECO:0000269|PubMed:11773441}.
CC   -!- PTM: Autophosphorylated. Phosphorylated by MAP2K6//MAPKK6, leading to
CC       PAK6 activation. {ECO:0000269|PubMed:15550393, ECO:0000269|Ref.12}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF276893; AAF82800.1; -; mRNA.
DR   EMBL; AJ236915; CAC18720.1; -; mRNA.
DR   EMBL; AK131522; BAG54772.1; -; mRNA.
DR   EMBL; AK290227; BAF82916.1; -; mRNA.
DR   EMBL; AK315813; BAF98704.1; -; mRNA.
DR   EMBL; AK315817; BAF98708.1; -; mRNA.
DR   EMBL; AC020658; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025429; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471125; EAW92395.1; -; Genomic_DNA.
DR   EMBL; CH471125; EAW92401.1; -; Genomic_DNA.
DR   EMBL; BC035596; AAH35596.1; -; mRNA.
DR   CCDS; CCDS10054.1; -. [Q9NQU5-1]
DR   CCDS; CCDS61590.1; -. [Q9NQU5-2]
DR   RefSeq; NP_001122100.1; NM_001128628.2. [Q9NQU5-1]
DR   RefSeq; NP_001122101.1; NM_001128629.2. [Q9NQU5-1]
DR   RefSeq; NP_001263646.1; NM_001276717.1. [Q9NQU5-1]
DR   RefSeq; NP_001263647.1; NM_001276718.1. [Q9NQU5-2]
DR   RefSeq; NP_064553.1; NM_020168.5. [Q9NQU5-1]
DR   PDB; 2C30; X-ray; 1.60 A; A=383-681.
DR   PDB; 2ODB; X-ray; 2.40 A; B=11-45.
DR   PDB; 4KS7; X-ray; 1.40 A; A=385-674.
DR   PDB; 4KS8; X-ray; 1.95 A; A=385-674.
DR   PDB; 6QDR; X-ray; 1.61 A; B=94-104.
DR   PDB; 6QDS; X-ray; 1.72 A; B=94-104.
DR   PDBsum; 2C30; -.
DR   PDBsum; 2ODB; -.
DR   PDBsum; 4KS7; -.
DR   PDBsum; 4KS8; -.
DR   PDBsum; 6QDR; -.
DR   PDBsum; 6QDS; -.
DR   AlphaFoldDB; Q9NQU5; -.
DR   SMR; Q9NQU5; -.
DR   BioGRID; 121251; 46.
DR   IntAct; Q9NQU5; 55.
DR   MINT; Q9NQU5; -.
DR   STRING; 9606.ENSP00000406873; -.
DR   BindingDB; Q9NQU5; -.
DR   ChEMBL; CHEMBL4311; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9NQU5; -.
DR   GuidetoPHARMACOLOGY; 2137; -.
DR   iPTMnet; Q9NQU5; -.
DR   PhosphoSitePlus; Q9NQU5; -.
DR   BioMuta; PAK6; -.
DR   DMDM; 23396789; -.
DR   EPD; Q9NQU5; -.
DR   jPOST; Q9NQU5; -.
DR   MassIVE; Q9NQU5; -.
DR   MaxQB; Q9NQU5; -.
DR   PaxDb; Q9NQU5; -.
DR   PeptideAtlas; Q9NQU5; -.
DR   PRIDE; Q9NQU5; -.
DR   ProteomicsDB; 34018; -.
DR   ProteomicsDB; 82189; -. [Q9NQU5-1]
DR   Antibodypedia; 10054; 545 antibodies from 38 providers.
DR   DNASU; 56924; -.
DR   Ensembl; ENST00000260404.8; ENSP00000260404.4; ENSG00000137843.12. [Q9NQU5-1]
DR   Ensembl; ENST00000441369.6; ENSP00000406873.1; ENSG00000137843.12. [Q9NQU5-1]
DR   Ensembl; ENST00000453867.7; ENSP00000401153.3; ENSG00000137843.12. [Q9NQU5-1]
DR   Ensembl; ENST00000455577.6; ENSP00000409465.2; ENSG00000137843.12. [Q9NQU5-2]
DR   Ensembl; ENST00000542403.3; ENSP00000439597.2; ENSG00000137843.12. [Q9NQU5-1]
DR   Ensembl; ENST00000558658.6; ENSP00000456785.2; ENSG00000137843.12. [Q9NQU5-1]
DR   Ensembl; ENST00000560346.5; ENSP00000453858.1; ENSG00000137843.12. [Q9NQU5-1]
DR   GeneID; 106821730; -.
DR   GeneID; 56924; -.
DR   KEGG; hsa:106821730; -.
DR   KEGG; hsa:56924; -.
DR   MANE-Select; ENST00000560346.6; ENSP00000453858.1; NM_001395430.1; NP_001382359.1.
DR   UCSC; uc001zky.5; human. [Q9NQU5-1]
DR   CTD; 106821730; -.
DR   CTD; 56924; -.
DR   DisGeNET; 106821730; -.
DR   DisGeNET; 56924; -.
DR   GeneCards; PAK6; -.
DR   HGNC; HGNC:16061; PAK6.
DR   HPA; ENSG00000137843; Tissue enhanced (esophagus, skin).
DR   MIM; 608110; gene.
DR   neXtProt; NX_Q9NQU5; -.
DR   OpenTargets; ENSG00000137843; -.
DR   PharmGKB; PA32921; -.
DR   VEuPathDB; HostDB:ENSG00000137843; -.
DR   eggNOG; KOG0578; Eukaryota.
DR   GeneTree; ENSGT00940000156528; -.
DR   HOGENOM; CLU_000288_26_6_1; -.
DR   InParanoid; Q9NQU5; -.
DR   OMA; HRQMPWP; -.
DR   PhylomeDB; Q9NQU5; -.
DR   TreeFam; TF105352; -.
DR   PathwayCommons; Q9NQU5; -.
DR   Reactome; R-HSA-428540; Activation of RAC1.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013405; RHOD GTPase cycle.
DR   Reactome; R-HSA-9013407; RHOH GTPase cycle.
DR   Reactome; R-HSA-9013424; RHOV GTPase cycle.
DR   SignaLink; Q9NQU5; -.
DR   SIGNOR; Q9NQU5; -.
DR   BioGRID-ORCS; 106821730; 1 hit in 19 CRISPR screens.
DR   BioGRID-ORCS; 56924; 15 hits in 1104 CRISPR screens.
DR   ChiTaRS; PAK6; human.
DR   EvolutionaryTrace; Q9NQU5; -.
DR   GeneWiki; PAK6; -.
DR   Pharos; Q9NQU5; Tchem.
DR   PRO; PR:Q9NQU5; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9NQU5; protein.
DR   Bgee; ENSG00000137843; Expressed in gingival epithelium and 144 other tissues.
DR   ExpressionAtlas; Q9NQU5; baseline and differential.
DR   Genevisible; Q9NQU5; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; TAS:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; TAS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0140058; P:neuron projection arborization; IEA:Ensembl.
DR   GO; GO:1990138; P:neuron projection extension; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:UniProtKB.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   CDD; cd01093; CRIB_PAK_like; 1.
DR   Gene3D; 3.90.810.10; -; 1.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR036936; CRIB_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR035066; PAK6.
DR   InterPro; IPR033923; PAK_BD.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   PANTHER; PTHR45832:SF3; PTHR45832:SF3; 1.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..681
FT                   /note="Serine/threonine-protein kinase PAK 6"
FT                   /id="PRO_0000086476"
FT   DOMAIN          12..25
FT                   /note="CRIB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00057"
FT   DOMAIN          407..658
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          26..406
FT                   /note="Linker"
FT   REGION          149..169
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..256
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          268..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..289
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        290..355
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        526
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         413..421
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         436
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         560
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         583..627
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056733"
FT   VARIANT         3
FT                   /note="R -> H (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs201346085)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035631"
FT   VARIANT         76
FT                   /note="M -> V (in dbSNP:rs2412504)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_019993"
FT   VARIANT         103
FT                   /note="R -> C (in dbSNP:rs36081263)"
FT                   /id="VAR_051655"
FT   VARIANT         151
FT                   /note="T -> I (in dbSNP:rs35593179)"
FT                   /id="VAR_051656"
FT   VARIANT         184
FT                   /note="E -> K (in dbSNP:rs56349744)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040972"
FT   VARIANT         205
FT                   /note="G -> E (in dbSNP:rs55920845)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040973"
FT   VARIANT         208
FT                   /note="P -> T (in dbSNP:rs35501648)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040974"
FT   VARIANT         210
FT                   /note="T -> M (in dbSNP:rs34869667)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040975"
FT   VARIANT         215
FT                   /note="H -> R (in dbSNP:rs3743135)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_019994"
FT   VARIANT         337
FT                   /note="P -> L (in dbSNP:rs3743137)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_019995"
FT   VARIANT         376
FT                   /note="A -> V (in dbSNP:rs55806501)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040976"
FT   VARIANT         475
FT                   /note="E -> K (in dbSNP:rs34445577)"
FT                   /id="VAR_051657"
FT   VARIANT         514
FT                   /note="L -> R (in a lung small cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040977"
FT   MUTAGEN         165
FT                   /note="S->A: Almost complete loss of PAK6 activation by
FT                   MAP2K6/MAPKK6; when associated with F-566."
FT                   /evidence="ECO:0000269|PubMed:15550393"
FT   MUTAGEN         560
FT                   /note="S->A: Complete loss of PAK6 activation by
FT                   MAP2K6/MAPKK6; when associated with A-165."
FT                   /evidence="ECO:0000269|PubMed:15550393"
FT   MUTAGEN         566
FT                   /note="Y->F: Complete loss of PAK6 activation by
FT                   MAP2K6/MAPKK6; when associated with A-165."
FT                   /evidence="ECO:0000269|PubMed:15550393"
FT   CONFLICT        60
FT                   /note="T -> A (in Ref. 3; BAG54772)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        381
FT                   /note="D -> G (in Ref. 3; BAG54772)"
FT                   /evidence="ECO:0000305"
FT   STRAND          16..27
FT                   /evidence="ECO:0007829|PDB:2ODB"
FT   TURN            28..31
FT                   /evidence="ECO:0007829|PDB:2ODB"
FT   STRAND          32..35
FT                   /evidence="ECO:0007829|PDB:2ODB"
FT   HELIX           38..44
FT                   /evidence="ECO:0007829|PDB:2ODB"
FT   HELIX           387..395
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           404..406
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          407..416
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          419..426
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   TURN            427..429
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          432..439
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   TURN            440..442
FT                   /evidence="ECO:0007829|PDB:2C30"
FT   HELIX           446..448
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           449..458
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          467..473
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          476..481
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           489..493
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           500..519
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           529..531
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          532..534
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          540..542
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           545..547
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   STRAND          553..555
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           565..567
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           570..573
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           581..596
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   TURN            600..603
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           606..615
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           624..626
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           629..638
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   TURN            643..645
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           649..653
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           656..660
FT                   /evidence="ECO:0007829|PDB:4KS7"
FT   HELIX           664..670
FT                   /evidence="ECO:0007829|PDB:4KS7"
SQ   SEQUENCE   681 AA;  74869 MW;  F20A4FA257649BB9 CRC64;
     MFRKKKKKRP EISAPQNFQH RVHTSFDPKE GKFVGLPPQW QNILDTLRRP KPVVDPSRIT
     RVQLQPMKTV VRGSAMPVDG YISGLLNDIQ KLSVISSNTL RGRSPTSRRR AQSLGLLGDE
     HWATDPDMYL QSPQSERTDP HGLYLSCNGG TPAGHKQMPW PEPQSPRVLP NGLAAKAQSL
     GPAEFQGASQ RCLQLGACLQ SSPPGASPPT GTNRHGMKAA KHGSEEARPQ SCLVGSATGR
     PGGEGSPSPK TRESSLKRRL FRSMFLSTAA TAPPSSSKPG PPPQSKPNSS FRPPQKDNPP
     SLVAKAQSLP SDQPVGTFSP LTTSDTSSPQ KSLRTAPATG QLPGRSSPAG SPRTWHAQIS
     TSNLYLPQDP TVAKGALAGE DTGVVTHEQF KAALRMVVDQ GDPRLLLDSY VKIGEGSTGI
     VCLAREKHSG RQVAVKMMDL RKQQRRELLF NEVVIMRDYQ HFNVVEMYKS YLVGEELWVL
     MEFLQGGALT DIVSQVRLNE EQIATVCEAV LQALAYLHAQ GVIHRDIKSD SILLTLDGRV
     KLSDFGFCAQ ISKDVPKRKS LVGTPYWMAP EVISRSLYAT EVDIWSLGIM VIEMVDGEPP
     YFSDSPVQAM KRLRDSPPPK LKNSHKVSPV LRDFLERMLV RDPQERATAQ ELLDHPFLLQ
     TGLPECLVPL IQLYRKQTST C
//
